S118: A CHEMOTHERAPY-FREE COMBINATION OF PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: SUBGROUP ANALYSIS FROM A PHASE II STUDY

• Nicholas Short,
• Elias Jabbour,
• Nitin Jain,
• Xuelin Huang,
• Walid Macaron,
• Lewis Nasr,
• Guillermo Montalban-Bravo,
• Tapan Kadia,
• Naval Daver,
• Kelly Chien,
• Yesid Alvarado,
• Ghayas Issa,
• Fadi Haddad,
• Cedric Nasnas,
• Marianne Zoghbi,
• Rebecca Garris,
• Marina Konopleva,
• Farhad Ravandi,
• Hagop Kantarjian

Affiliations

Nicholas Short

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Elias Jabbour

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Nitin Jain

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Xuelin Huang

2 The University of Texas MD Anderson Cancer Center, Biostatistics, Houston, United States

Walid Macaron

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Lewis Nasr

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Guillermo Montalban-Bravo

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Tapan Kadia

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Naval Daver

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Kelly Chien

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Yesid Alvarado

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Ghayas Issa

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Fadi Haddad

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Cedric Nasnas

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Marianne Zoghbi

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Rebecca Garris

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Marina Konopleva

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Farhad Ravandi

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States

Hagop Kantarjian

1 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, United States